A virologist said that a vaccine normally takes at least 12-18 months to pass all necessary clinical trial phases while the company developing it has just over a month to wrap up everything
Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost
Hyderabad-based Bharat Biotech, one of seven Indian companies involved in the indigenous production of a vaccine for the novel coronavirus, received the green signal from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of 'Covaxin' last week.
COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.
Coronavirus Updates: Centre tells states to enable all doctors, including private practitioners, to prescribe COVID-19 tests
Coronavirus LIVE Updates: Union health secretary Preeti Sudan and ICMR director general Balram Bhargava on Wednesday wrote to state governments and Union territories to increase testing.
The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month.
Potential COVID-19 vaccines: From a self-limiting virus to a self-assembling vaccine, scientists are pulling out all the stops
There is currently no authorized treatment for the infection, though various governments have green-lighted emergency treatments with little evidence.
Billed as one of the first novel vaccines to be developed completely in the developing world, it is expected to help in significant reduction in infant deaths due to Rotavirus diarrhoea in India and other parts of the world.
The old model - of pharma companies deciding what and when to develop new drugs – is crumbling.